The CeriBell, Inc. team celebrating at the Nasdaq Exchange.
Hear from Dr. Josef Parvizi and Dr. Chris Chafe about their
Stanford Bio-X Seed Grant that launched CeriBell, Inc.!
In 2012, Stanford Bio-X affiliated faculty members Josef Parvizi and Chris Chafe received a Stanford Bio-X Seed Grant, “The Brain in Performance: Converting Brain Waves to Sound and Image” to create a stethoscope device for the brain.
This Seed Grant launched CeriBell, Inc. – which made its market debut on Friday, October 11 in an IPO that is expected to generate $180.3 million in proceeds!
Read more:
CeriBell’s Press Release The Wall Street Journal Nasdaq Exchange Announcement
